Tricuspid regurgitation and long-term clinical outcomes
Ehud Chorin(Ben-Gurion University of the Negev), Shmuel Banai(Tel Aviv Sourasky Medical Center), Maayan Konigstein(Tel Aviv University), Eyal Richert(Tel Aviv University), Zach Rozenbaum(Tel Aviv University), Yan Topilsky(Tel Aviv Sourasky Medical Center), Gad Keren(Assuta Medical Center), Tomer Ziv‐Baran(Tel Aviv University)
Cited by 268
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347